Crónicas de autores

Jesús Fortún *

Autor invitado por SIIC

El trabajo destaca el papel de la PCR en orina como factor diferencial entre TBC pulmonar y extrapulmonar

ASPECTOS DIFERENCIALES Y PAPEL DE LA PCR EN LA TUBERCULOSIS EXTRAPULMONAR

El trabajo compara los aspectos clínicos más significativos de las tuberculosis extrapulmonares en relación con las formas pulmonares, destacando a la mayor mortalidad, la mayor frecuencia de infección por VIH, la mayor edad y la PCR en orina como variables independientes asociadas.

*Jesús Fortún
describe para SIIC los aspectos relevantes de su trabajo
EXTRA-PULMONARY TUBERCULOSIS: DIFFERENTIAL ASPECTS AND ROLE OF 16S-RRNA IN URINE
International Journal of Tuberculosis and Lung Disease,
18(4):478-485 Abr, 2014

Esta revista, clasificada por SIIC Data Bases, integra el acervo bibliográfico
de la Biblioteca Biomédica (BB) SIIC.

Institución principal de la investigación
*Hospital Ramon y Cajal, Madrid, España, Madrid, España
Imprimir nota
Comprar este artículo
Otros artículos escogidos
Referencias bibliográficas
1. European Centre for Disease Prevention and Control: Accessed 2 July 2012. European Tuberculosis Surveillance Network. Available at: http:// www.ecdc.europa.eu/en/activities/surveillance/european_tuberculosis_surveillance_network/Pages/index.aspx
2.. Sandgren A, Hollo V, van der Werf MJ. Extrapulmonary tuberculosis in the European Union and European Economic Area, 2002 to 2011. Euro Surveill.2013;18(12):pii=20431. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20431
3. Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis 2009;49(9):1350-7.
4. Yang Z, Kong Y, Wilson F, Foxman B, Fowler AH, Marrs CF, et al. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis 2004; 38: 199–205.
5. Ilgazli A, Boyaci H, Basyigit I, Yildiz F. Extra-pulmonary tuberculosis: clinical and epidemiologic spectrum of 636 cases. Arch Med Res 2004; 35: 435–441.
6. Leeds IL, Magee MJ, Kurbatova EV, Del Rio C, Blumberg HM, Leonard MK, Kraft CS. Site of extrapulmonary tuberculosis is associated with HIV infection. Clin Infect Dis 2012;55(1):75-81.
7. Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993; 148:1292–7.
8. Fortún J, Martín-Dávila P, Navas E, López-Vélez R, Pintado V, Cobo J, et al.
Changes in the epidemiology of tuberculosis: the influence of international migration flows. Enferm Infecc Microbiol Clin 2011;29(9):654-9.
9. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003; 362:887–99.
10. Diagnostic standards and classification of tuberculosis in adults and children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000; 161 (4 Pt 1): 1376–1395.
11. Centers for Disease Control and Prevention (CDC). Vital signs: current cigarette smoking among adults aged >or=18 years — United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59:1135–40.
12. CDC. Update Guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep. 2009;58:7-10.
13. Kruijshaar ME, Abubakar I. Increase in extrapulmonary tuberculosis in England and Wales 1999-2006. Thorax. 2009 Dec;64(12):1090-5.
14. García-Rodríguez JF, Álvarez-Díaz H, Lorenzo-García MV, Mariño-Callejo A, Fernández-Rial A, Sesma-Sánchez P. Extrapulmonary tuberculosis: epidemiology and risk factors. Enferm Infecc Microbiol Clin. 2011 Aug-Sep;29(7):502-9.
15. Forssbohm M, Zwahlen M, Loddenkemper R, Rieder HL. Demographic characteristics of patients with extrapulmonary tuberculosis in Germany. Eur Respir J 2008;31:99–105.
16. Cowie RL, Sharpe JW. Extra-pulmonary tuberculosis: a high frequency in the absence of HIV infection. Int J Tuberc Lung Dis 1997;1:159–62.
17. Havlir DV, Barnes PF. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1999;340:367–73.
18. Kim CH, Lim JK, Lee SY, Won DI, Cha SI, Park JY, Lee WK, Lee J. Predictive factors for tuberculosis in patients with a TB-PCR-negative bronchial aspirate. Infection 2013;41(1):187-94. doi: 10.1007/s15010-012-0394-7. Epub 2013 Jan
3. PubMed PMID: 23283746.
19. Kombila DU, Moussavou-Kombila JB, Grobusch MP, Lell B. Clinical and laboratory features of tuberculosis within a hospital population in Libreville, Gabon.
Infection 2012. Dec 13[Epub ahead of print] PubMed PMID: 23239164.
20. Kocher C, Weber R, Friedl A. A case study of female genital tuberculosis in a Western European setting. Infection 2011;39(1):59-63.
21. Musellim B, Erturan S, Sonmez DE, Ongen G. Comparison of extra-pulmonary and pulmonary tuberculosis cases: factors influencing the site of reactivation. Int J Tuberc Lung Dis 2005;9:1220–3.
22. Verdon R, Chevret S, Laissy JP, Wolff M. Tuberculous meningitis in adults: review of 48 cases. Clin Infect Dis 1996; 22:982–8.
23. Kingkaew N, Sangtong B, Amnuaiphon W, Jongpaibulpatana J, Mankatittham W, Akksilp S, et al. HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death. Int J Infect Dis 2009; 13:722–9.
24. Friedman LN, Williams MT, Singh TP, Frieden TR. Tuberculosis, AIDS, and death among substance abusers on welfare in New York City. N Engl J Med 1996; 334:828–33.
25. te Beek LA, van der Werf MJ, Richter C, Borgdorff MW. Extrapulmonary tuberculosis by nationality, The Netherlands, 1993–2001. Emerg Infect Dis 2006; 12:1375–82.
26. Green C, Huggett JF, Talbot E, Mwaba P, Reither K, Zumla AI. Rapid diagnosis of tuberculosis through the detection of mycobacterial DNA in urine by nucleic acid amplification methods. Lancet Infect Dis. 2009 Aug;9(8):505-11.
27. Moussa O M, Eraky I, El-Far M A, Osman H G, Ghoneim M A. Rapid diagnosis of genitourinary tuberculosis by polymerase chain reaction and non-radioactive DNA hybridization. J Urol 2000; 164: 584–588.
28. Umansky S, Tomei LD. Transrenal DNA testing: progress and perspectives. Expert Rev Mol Diagn 2006; 6: 153–63.
29. Cannas A, Goletti D, Girardi E, Chiacchio T, Calvo L, Cuzzi G, et al. Mycobacterium tuberculosis DNA detection in soluble fraction of urine from
pulmonary tuberculosis patients. Int J Tuberc Lung Dis. 2008 Feb;12(2):146-51.
30. Alcaide F, Coll P. Advances in rapid diagnosis of tuberculosis disease and
anti-tuberculous drug resistance. Enferm Infecc Microbiol Clin 2011 Mar;29 Suppl
1:34-40.
31. Neonakis IK, Gitti Z, Krambovitis E, Spandidos DA. Molecular diagnostic tools in mycobacteriology. J Microbiol Methods. 2008;75:1-11
32. Lawn SD. Point-of-care detection of lipoarabinomannan (LAM) in urine for
diagnosis of HIV-associated tuberculosis: a state of the art review. BMC Infect
Dis. 2012 Apr 26;12:103.
33. Cannas A, Calvo L, Chiacchio T, Cuzzi G, Vanini V, Lauria FN, et al. IP-10 detection in urine is associated with lung diseases. BMC Infect Dis. 2010 Nov 22;10:333.
Otros artículos de Jesús Fortún

1: Fortún J, Meije Y, Buitrago MJ, Gago S, Bernal-Martinez L, Pemán J, Pérez M,
Gómez-G Pedrosa E, Madrid N, Pintado V, Martín-Dávila P, Cobo J, Fresco G, Moreno
S, Cuenca-Estrella M. Clinical validation of a multiplex real-time PCR assay for
detection of invasive candidiasis in intensive care unit patients. J Antimicrob
Chemother. 2014 Jun 25. pii: dku225. [Epub ahead of print] PubMed PMID: 24970743.


2: Meije Y, Fortún J, Len Ó, Aguado JM, Moreno A, Cisneros JM, Gurguí M,
Carratalà J, Muñoz P, Montejo M, Blanes M, Bou G, Pérez JL, Torre-Cisneros J,
Ramos A, Pahissa A, Gavaldà J; Spanish Network for Research on Infection in
Transplantation (RESITRA) and the Spanish Network for Research on Infectious
Diseases (REIPI). Prevention strategies for cytomegalovirus disease and long-term
outcomes in the high-risk transplant patient (D+/R-): experience from the
RESITRA-REIPI cohort. Transpl Infect Dis. 2014 Jun;16(3):387-96. doi:
10.1111/tid.12226. Epub 2014 May 8. PubMed PMID: 24807640.


3: Fortún J, Martín-Dávila P, Gómez-Mampaso E, Vallejo A, Cuartero C,
González-García A, Rubí J, Pallarés E, Moreno S. Extra-pulmonary tuberculosis: a
biomarker analysis. Infection. 2014 Aug;42(4):649-54. doi:
10.1007/s15010-014-0602-8. Epub 2014 Mar 21. PubMed PMID: 24652106.


4: Fortún J, Centella T, Martín-Dávila P, Lamas MJ, Pérez-Caballero C,
Fernández-Pineda L, Otheo E, Cobo J, Navas E, Pintado V, Loza E, Moreno S.
Infective endocarditis in congenital heart disease: a frequent community-acquired
complication. Infection. 2013 Feb;41(1):167-74. doi: 10.1007/s15010-012-0326-6.
Epub 2012 Sep 7. PubMed PMID: 22956474.


5: Fortún J, Ruiz I, Martín-Dávila P, Cuenca-Estrella M. Fungal infection in
solid organ recipients. Enferm Infecc Microbiol Clin. 2012 Mar;30 Suppl 2:49-56.
doi: 10.1016/S0213-005X(12)70082-4. PubMed PMID: 22542035.


6: Fortún J, Martín-Dávila P, Gómez-García de la Pedrosa E, Pintado V, Cobo J,
Fresco G, Meije Y, Ros L, Alvarez ME, Luengo J, Agundez M, Belso A, Sánchez-Sousa
A, Loza E, Moreno S. Emerging trends in candidemia: a higher incidence but a
similar outcome. J Infect. 2012 Jul;65(1):64-70. doi: 10.1016/j.jinf.2012.02.011.
Epub 2012 Feb 24. PubMed PMID: 22369861.


7: Fortún J, Martín-Dávila P, Navas E, López-Vélez R, Pintado V, Cobo J,
González A, Bonilla M, Aneiros V, Gómez-Mampaso E, Moreno S. Changes in the
epidemiology of tuberculosis: the influence of international migration flows.
Enferm Infecc Microbiol Clin. 2011 Nov;29(9):654-9. doi:
10.1016/j.eimc.2011.04.002. Epub 2011 Jun 30. PubMed PMID: 21723001.


8: Fortún J, Carratalá J, Gavaldá J, Lizasoain M, Salavert M, de la Cámara R,
Borges M, Cervera C, Garnacho J, Lassaleta Á, Lumbreras C, Sanz MÁ, Ramos JT,
Torre-Cisneros J, Aguado JM, Cuenca-Estrella M; Grupo de Estudio de Micología
Médica de la SEIMC (GEMICOMED). [Guidelines for the treatment of invasive fungal
disease by Aspergillus spp. and other fungi issued by the Spanish Society of
Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update]. Enferm
Infecc Microbiol Clin. 2011 Jun-Jul;29(6):435-54. doi:
10.1016/j.eimc.2011.01.010. Epub 2011 Apr 6. Spanish. PubMed PMID: 21474210.


9: Fortun J, Martin-Davila P, Pascual J, Cervera C, Moreno A, Gavalda J, Aguado
JM, Pereira P, Gurguí M, Carratala J, Fogueda M, Montejo M, Blasco F, Bou G,
Torre-Cisneros J; RESITRA Transplant Network. Immunosuppressive therapy and
infection after kidney transplantation. Transpl Infect Dis. 2010
Oct;12(5):397-405. doi: 10.1111/j.1399-3062.2010.00526.x. PubMed PMID: 20553437.


10: Fortún J, Martín-Dávila P, Méndez R, Martínez A, Norman F, Rubi J, Pallares
E, Gómez-Mampaso E, Moreno S. Ca-125: a useful marker to distinguish pulmonary
tuberculosis from other pulmonary infections. Open Respir Med J. 2009 Nov
20;3:123-7. doi: 10.2174/1874306400903010123. PubMed PMID: 19966922; PubMed
Central PMCID: PMC2788741.


11: Aguado JM, Torre-Cisneros J, Fortún J, Benito N, Meije Y, Doblas A, Muñoz P.
[Consensus document for the management of tuberculosis in solid organ transplant
recipients]. Enferm Infecc Microbiol Clin. 2009 Oct;27(8):465-73. doi:
10.1016/j.eimc.2008.10.008. Epub 2009 May 23. Spanish. PubMed PMID: 19477046.


12: Torre-Cisneros J, Doblas A, Aguado JM, San Juan R, Blanes M, Montejo M,
Cervera C, Len O, Carratala J, Cisneros JM, Bou G, Muñoz P, Ramos A, Gurgui M,
Borrell N, Fortún J, Moreno A, Gavalda J; Spanish Network for Research in
Infectious Diseases. Tuberculosis after solid-organ transplant: incidence, risk
factors, and clinical characteristics in the RESITRA (Spanish Network of
Infection in Transplantation) cohort. Clin Infect Dis. 2009 Jun
15;48(12):1657-65. doi: 10.1086/599035. PubMed PMID: 19445585.

Para comunicarse con Jesús Fortún mencionar a SIIC como referencia:
fortunabete@gmail.com

Autor invitado
15 de agosto, 2014
Descripción aprobada
21 de agosto, 2014
Reedición siicsalud
2 de febrero, 2024

Acerca del trabajo completo
ASPECTOS DIFERENCIALES Y PAPEL DE LA PCR EN LA TUBERCULOSIS EXTRAPULMONAR

Título original en castellano
TUBERCULOSIS EXTRAPULMONAR: ASPECTOS DIFERENCIALES Y PAPEL DE 16S-RRNA EN ORINA

Autor
Jesús Fortún1, Pilar Martín-Dávila2, Enrique Gómez-Mampaso3, Antonio González-García4, Ignacio Borbolla5, Parick Wickman6, Judith Ortiz7, Enrique Navas8, Cluadio Cuartero9
1 Medico (phd), Hospital Ramon y Cajal, Madrid, España, Madrid, España, Jefe de Sección
2 Médico
3 Médico
4 Médico
5 Médico
6 Médico
7 Médico
8 Médico
9 Farmacéutico

Acceso a la fuente original
International Journal of Tuberculosis and Lung Disease
https://www.theunion.org/what-we-do/journals

El artículo se relaciona estrictamente con las especialidades de siicsalud
El artículo se conecta secundariamente con las especialidades
    


ua40317